facebooktwittertelegramwhatsapp
copy short urlprintemail
+ A
A -
webmaster

Tribune News Network
Doha
Qatar Foundation's (QF) Stars of Science decided its four grand finalists on Saturday, giving way for the jury and live audiences to vote for their favourite innovator with an equal 50/50 voting power.
Nour Majbour, a research associate from Hamad Bin Khalifa University's (HBKU) Qatar Biomedical Research Institute (QBRI), is competing as a Qatar-based finalist and is displaying her innovative strides in early Parkinson's disease (PD) diagnostics, which carry great entrepreneurial promise for the biotech industry in Qatar.
A powerful champion for women in Science, Technology, Engineering and Mathematics (STEM) worldwide, Majbour gained prominence with her innovative Parkinson's Early Detection Kit, which leverages naturally-occurring antibodies within the human immune system to identify biological signs of the onset of Parkinson's disease (PD).
The kit utilises antibodies that capture the form of protein that causes PD. PD is a neurodegenerative condition that affects about 10 million people worldwide, making it the second most common age-related neurodegenerative disorder after Alzheimer's disease.
Majbour said,"Many years of chess games with my older brother have honed my patience and competitive spirit and both became invaluable assets throughout my journey at Stars of Science. Taking my research from QBRI's laboratories to a global television audience meant that I had to adapt to a new level of visibility. However, I am honoured that the jury recognised the value of my prototype and supported my ascent to the finale."
Majbour plans to use her share to develop her kit for an up-and-coming Qatari biotech company that will seek to innovate new scientific tools to facilitate early diagnosis, treatment and management of devastating diseases.
The show forms a microcosm of real-market conditions where an innovation is tested against certain parameters, including prototype performance, industrial design and customer validation. Ultimately, her product's successful performance in each of these categories underpins the future marketability of her Parkinson's Early Detection Kit.
In the process, HBKU's support proved instrumental in the development of an impactful and viable prototype that carries the potential to mature into a fully-integrated diagnostics solution and overhaul patient care for generations to come.
This season's competition further underlines Majbour's cutting-edge contribution to medical science whose relevance is projected to increase as the incidence of PD rises proportionally to globally improved life expectancy figures.
As an HBKU innovator, Majbour continues to embody the University's values of creativity and excellence, whilst doubling as a role model for female independence and leadership in STEM professions. Throughout her appearances on the show, she successfully manages to overcome technical challenges and showcase great perseverance, which led to her placement within the finale.
copy short url   Copy
19/11/2018
520